ODDB.org: Open Drug Database

Mepha Pharma AG - Montelukast-Mepha 5 mg, Kautabletten

Swissmedic Registration	62361	Sequence	02
Product name	Montelukast-Mepha 5 mg	Description	Kautabletten
ATC-Classification	R03DC03	ATC-Description	Montelukast
Introduction of Sequence	19.12.2012

Composition

montelukastum 5 mg ut montelukastum natricum, mannitolum, natrii laurilsulfas, hydroxypropylcellulosum, carboxymethylamylum natricum A, magnesii stearas, aromatica (Kirsche) cum eugenolum et citralum et limonenum, aspartamum 0.5 mg, E 172 (rubrum), pro compresso, natrium 0.85 mg.

Packungsbestandteile

Galenic Form

Chewing tablets

Active Agent	Dose
Montelukast	5 mg

BAG: Active Agent	Dose
Montelukast	5 mg

Inactive agents	Dose	additional_information
(Rubrum)
Aromatica (Kirsche) cum Eugenolum
Aspartame	0.5 mg
Carboxymethylamylum Natricum A
Citral
E 172		color.
Hydroxypropylcellulosum
Limonenum
Magnesii Stearas
Mannitol
Natrii Laurilsulfas
Sodium	0.85 mg
Pro Compresso

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	28 Tablet(s)	16.79	34.70	B	SL	Yes
004	98 Tablet(s)	58.62	80.15	B	SL	Yes

2025	©ywesee GmbH